XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statement of Operations - USD ($)
$ in Thousands
 3 Months Ended 5 Months Ended 6 Months Ended
Jun. 28, 2020
Jun. 30, 2019
Jun. 30, 2019
Jun. 28, 2020
Operations Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses 0 0 0 0
Other (income)/deductions—net 1,200 0 0 1,200
Loss before benefit for taxes on income (1,200) 0 0 (1,200)
Benefit for taxes on income (300) 0 0 (279)
Net loss $ (900) $ 0 $ 0 $ (900)
Loss per common share—basic and diluted(a) [1] $ (9,071) $ 0 $ 0 $ (9,071)
Weighted-average common shares—basic and diluted(a) [1] 100 100 100 100
[1] All common shares issued and outstanding were held by Pfizer Inc. (see Note 1A. Organization and Basis of Presentation: Organization and Note 7. Equity).